Oxytocin
OXT
Oxytocin (OXT) is a hormonal & sexual research compound. Hypothalamic peptide hormone driving bonding, trust and social/mood effects, plus smooth-muscle actions.
Oxytocin quick facts
| Reported research dosing | 10-100mcg |
| Route | Subq |
| Cycle length | As Needed |
| Frequency | 1x Daily · As Needed |
| Half-life | ~1-6 min (IV); ~90 min intranasal |
| Forms | Injectable, Nasal |
| Evidence level | Human (clinical) |
Mood/connection and intimacy angle. Very short-acting — timing is everything.
How Oxytocin works
Hypothalamic peptide hormone driving bonding, trust and social/mood effects, plus smooth-muscle actions.
Proposed benefits
Bonding, mood, stress-buffering and social/sexual effects.
✅ Clinically validated
- A long-established human drug — intravenous oxytocin (Pitocin) is used worldwide to induce labour and control postpartum haemorrhage, so the systemic pharmacology and safety are thoroughly characterised.
- Intranasal oxytocin for social and psychiatric endpoints has been trialled extensively and the results have largely not replicated — early positive findings in autism and social cognition faded at scale, and a large NIH-funded autism trial was null.
- The interesting part is why, because it is probably not the hormone's fault. Oxytocin is a large charged peptide and how much of an intranasal dose reaches the brain is genuinely unsettled. The trials that failed were testing a drug, a delivery route and a dose simultaneously, and a null result cannot tell you which of the three was wrong. The intravenous obstetric evidence shows the molecule does exactly what it is supposed to when it definitely arrives.
📊 Correlative data
- Used off-label for bonding, anxiety and sexual function. The reported experience is real but subtle and highly context-dependent — which matches the trial literature, where effects appear and disappear depending on the social setting of the test.
🧪 Theoretical / extrapolated
- A nonapeptide acting on oxytocin receptors in the hypothalamus and limbic system. How much intranasal oxytocin reaches the brain at all is the unresolved question underneath the whole field — the replication failures may be a delivery problem rather than a biology problem.
- The receptor overlaps with vasopressin's, which predicts the blood-pressure and fluid-balance effects seen at higher doses, and is the reason it is not a casual compound at scale.
These tiers tell you how much human evidence exists — not how well something works. This is the research space, and most of what’s in here is new rather than disproven. Something sitting at “theoretical” usually means nobody has funded the trial, not that the trial was run and failed.
The trap runs the other way too: something can be clinically validated and still do very little for you specifically. A statistically significant result in a study population is not a promise about your body.
- ✅ Clinically validated — human randomised trials or meta-analyses support it. The strongest footing available.
- 📊 Correlative — observational or epidemiological data. Suggestive, and genuinely useful for direction, but it cannot establish cause.
- 🧪 Theoretical / mechanistic — the mechanism is understood and often demonstrated in cells or animals, and the human trial doesn’t exist yet. Unproven is not the same as ineffective. Plenty of what’s standard practice today sat here five years ago.
✗ is a safety flag, not a grade. Where you see it, the concern is harm — not a disappointing trial. A compound tested for one purpose and found not to help there can still be worth studying somewhere else, so a negative result never gets rendered as a cross. It sits alongside the tier, because something can be both well-studied and genuinely risky.
My job is to tell you which one you’re looking at, and let you make the call. Grading something low isn’t me dismissing it — it’s me refusing to oversell it. This is the research space, and being able to reason forward from a mechanism matters as much as waiting for the trial.
Oxytocin — safety, predicted from mechanism
Much of this compound class has never been through a human safety trial. Rather than say nothing — or print a generic warning — this is what its known mechanism predicts could go wrong, and what you can do about it. Predictions are labelled as predictions.
What the mechanism predicts
Derived from what this molecule does, not from a trial.
- These act on the top of the reproductive axis, and which direction they push depends on how they are given. hCG and gonadorelin stimulate; kisspeptin stimulates upstream of GnRH. Continuous GnRH agonism (triptorelin) paradoxically SUPPRESSES after an initial flare, because sustained signalling desensitises the receptor. Cetrorelix is a straightforward antagonist and suppresses immediately.
- The predicted harm follows the direction: stimulation raises testosterone and estradiol together, so aromatisation-driven effects arrive with it. Suppression produces a hypogonadal state — low libido, fatigue, mood change, and bone loss if prolonged.
- The initial FLARE on a GnRH agonist is the specific thing to know about: hormones rise sharply before they fall, and symptoms can transiently worsen.
What has actually been reported
- hCG is well characterised in fertility medicine — gynaecomastia and fluid retention from the estradiol rise are the common complaints.
- GnRH agonist flare is documented and clinically managed in oncology with an antiandrogen during the first weeks.
How to reduce the risk
Each of these follows from the same mechanism as the prediction.
- If using hCG alongside an androgen to preserve testicular function, lower and more frequent beats large and infrequent — the estradiol spike tracks the dose size.
- Anything suppressing the axis for more than a few months needs a bone density conversation, not just a hormone panel.
What it does to your bloodwork
A fact about the assay, not a guess about the drug.
- LH and FSH, total and free testosterone, sensitive estradiol (these raise it more than people expect), and a semen analysis if fertility is the reason you are running it.
Don't run this if
- You have a hormone-sensitive cancer, unless this is being directed by an oncologist — in which case it is their protocol, not one to self-manage.
The honest unknown
- Kisspeptin analogues are early in human study. The axis effect is real and well demonstrated acutely; the consequences of repeated long-term use are not established.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Food is not a factor — pick a time you will keep
Nothing you eat touches a subcutaneous injection, so there is no meal to plan around. What does matter is a fixed slot: the commonest reason an injectable protocol underperforms is missed doses, not mistimed ones.
With a short half-life, dose it near the effect you want rather than at a fixed hour.
Derived from half-life, route and mechanism — not from a dosing trial. Reasoned, and labelled as reasoned.
Oxytocin reconstitution calculator
Research reconstitution calculator
Where to get Oxytocin
Buy Oxytocin at AminoWell USA →Oxytocin — interference & stacking
Predicted from mechanism, not from an interaction study. There are no trials of these combinations — what follows is what the biology implies, so treat it as a reason to watch something, not as a finding.
What Oxytocin moves on your bloodwork
These are the markers this compound is expected to move, and which direction. Knowing that in advance is mostly about NOT panicking: some of these moving is the compound working.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
Most of this class has no predicted marker movement at all, and saying so is more useful than listing markers that will not move.
What to do: A baseline liver panel is reasonable for anything taken daily and long-term. Beyond that there is nothing specific to chase.
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Get the complete breakdown for Oxytocin — inside the Academy alongside the full interactive Vault.
Unlock in the Academy — $10/mo →Bloodwork to run alongside Oxytocin
Run these before you start, and again after 8–12 weeks. A baseline you didn’t take is one you can never go back for.
| Marker | What it’s watching for |
|---|---|
| Comprehensive Metabolic Panel (CMP) | Sodium. High-dose or repeated oxytocin can cause dangerous hyponatraemia |
| Prolactin | Moves with oxytocin and confounds hormone panels |
The The Basics — Start Here panel covers these in one order — 4 markers, $32.40 with the discount applied.
Check results you already have → · All 102 markers A–Z
Oxytocin — frequently asked questions
What is Oxytocin?
Oxytocin (OXT) is a hormonal & sexual research compound. Hypothalamic peptide hormone driving bonding, trust and social/mood effects, plus smooth-muscle actions.
What dosing does the research reference for Oxytocin?
In the research literature, Oxytocin is referenced in the 10-100mcg range, 1x Daily · As Needed. It is supplied as a lyophilized powder and reconstituted with bacteriostatic water; the calculator above converts a research amount into syringe units. For research use only — not a recommendation for human use.
What is the half-life of Oxytocin?
Oxytocin has an approximate half-life of ~1-6 min (IV); ~90 min intranasal, which is part of what determines how often it's dosed.
What forms does Oxytocin come in?
Oxytocin is available as: Injectable, Nasal.
What's the evidence behind Oxytocin?
Current evidence level: Human (clinical). Oxytocin is offered for research purposes only and is not an approved medicine.
Want Coach Cam's exact Oxytocin protocol?
Dosing schedules, stacking, cycle timing and my personal notes live inside the Academy — plus the full interactive Vault of 237 compounds & 350 supplements.
Join the Academy — $10/mo →What Oxytocin is used for
Oxytocin appears under 1 goal in the Vault’s goal router, grouped by the mechanism it works through rather than by how much trial evidence exists. Each link opens that pathway in full, with the alternatives beside it and the bloodwork that tests it.